Improving attribution of adverse events in oncology clinical trials.

George, Goldy C

Improving attribution of adverse events in oncology clinical trials. [electronic resource] - Cancer treatment reviews Jun 2019 - 33-40 p. digital

Publication Type: Journal Article; Review

1532-1967

10.1016/j.ctrv.2019.04.004 doi


Adverse Drug Reaction Reporting Systems
Antineoplastic Agents--adverse effects
Clinical Trials, Phase III as Topic--methods
Drug Development--methods
Humans
Randomized Controlled Trials as Topic--methods